Published in Infect Immun on May 01, 2002
Development of Galleria mellonella as an alternative infection model for the Burkholderia cepacia complex. Infect Immun (2008) 1.55
Comparative analysis of plant and animal models for characterization of Burkholderia cepacia virulence. Infect Immun (2003) 1.41
Colonial morphology of Burkholderia cepacia complex genomovar III: implications in exopolysaccharide production, pilus expression, and persistence in the mouse. Infect Immun (2003) 1.08
A LysR-type transcriptional regulator in Burkholderia cenocepacia influences colony morphology and virulence. Infect Immun (2007) 1.07
Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine. Med Microbiol Immunol (2009) 0.94
Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers. Int Arch Med (2008) 0.93
Distribution and expression of the ZmpA metalloprotease in the Burkholderia cepacia complex. J Bacteriol (2005) 0.90
Virulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease. Infect Immun (2009) 0.90
Drosophila melanogaster as a model host for the Burkholderia cepacia complex. PLoS One (2010) 0.88
Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections. Antimicrob Agents Chemother (2014) 0.86
Identification of Burkholderia cepacia complex bacteria with a lipopolysaccharide-specific monoclonal antibody. J Med Microbiol (2010) 0.83
Persistence of Burkholderia multivorans within the pulmonary macrophage in the murine lung. Infect Immun (2004) 0.82
Colony morphology variation of Burkholderia pseudomallei is associated with antigenic variation and O-polysaccharide modification. Infect Immun (2015) 0.81
Identification of potential diagnostic markers among Burkholderia cenocepacia and B. multivorans supernatants. J Clin Microbiol (2010) 0.80
An In vitro Study of Bio-Control and Plant Growth Promotion Potential of Salicaceae Endophytes. Front Microbiol (2017) 0.75
Phylogeographic, genomic, and meropenem susceptibility analysis of Burkholderia ubonensis. PLoS Negl Trop Dis (2017) 0.75
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev (1991) 7.12
Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol (1992) 6.40
Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol (1996) 4.11
Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol (2000) 3.77
Burkholderia cepacia. Management issues and new insights. Clin Chest Med (1998) 3.23
Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest (1987) 2.97
Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis (2002) 2.26
Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun (1996) 1.82
Role of ornibactin biosynthesis in the virulence of Burkholderia cepacia: characterization of pvdA, the gene encoding L-ornithine N(5)-oxygenase. Infect Immun (1999) 1.70
Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol (1990) 1.69
Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice. Infect Immun (1983) 1.57
Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology (1999) 1.51
Pathogenicity of microbes associated with cystic fibrosis. Microbes Infect (1999) 1.50
Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect Immun (1998) 1.47
Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products. Infect Immun (1997) 1.44
Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nat Genet (1995) 1.37
Preferential adherence of cable-piliated burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants. J Med Microbiol (2000) 1.28
Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol Med Microbiol (1995) 1.24
Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells. Infect Immun (2000) 1.20
Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice. Infect Immun (2001) 1.19
Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect Immun (1997) 1.11
Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis. Pediatr Pulmonol (2000) 1.09
Clinical and environmental isolates of Burkholderia cepacia exhibit differential cytotoxicity towards macrophages and mast cells. Mol Microbiol (2000) 1.08
In vitro resistance of Burkholderia cepacia complex isolates to reactive oxygen species in relation to catalase and superoxide dismutase production. Microbiology (2001) 1.01
Mouse models of cystic fibrosis. Trends Genet (2001) 1.00
Invasion of murine respiratory epithelial cells in vivo by Burkholderia cepacia. J Med Microbiol (2001) 1.00
A murine model for infection with Burkholderia cepacia with sustained persistence in the spleen. Infect Immun (1999) 1.00
The effect of treatment with interleukin-1 and tumor necrosis factor on Pseudomonas aeruginosa lung infection in a granulocytopenic mouse model. Clin Immunol Immunopathol (1994) 0.95
Influence of cytostatic agents on the pulmonary defence of mice infected with Klebsiella pneumoniae and on the efficacy of treatment with ceftriaxone. J Infect (1994) 0.84
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A (2006) 8.85
A randomized controlled trial of peripheral blood mononuclear cell depletion in experimental human lung inflammation. Am J Respir Crit Care Med (2013) 2.71
Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol (2009) 2.61
The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol (2002) 2.57
Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med (2002) 2.40
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore) (2010) 2.26
Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol (2005) 2.17
Impact of LL-37 on anti-infective immunity. J Leukoc Biol (2004) 2.01
Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax (2009) 1.87
Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunol Med Microbiol (2002) 1.86
Monocytes control second-phase neutrophil emigration in established lipopolysaccharide-induced murine lung injury. Am J Respir Crit Care Med (2012) 1.82
The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol (2004) 1.78
A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci (2005) 1.78
Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother (2005) 1.67
Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative Staphylococcus in a neonatal intensive care unit. Pediatrics (2006) 1.63
The role of the purinergic P2X7 receptor in inflammation. J Inflamm (Lond) (2007) 1.50
Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo. MBio (2010) 1.50
The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J Immunol (2004) 1.41
Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One (2011) 1.39
Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B. Eur J Immunol (2007) 1.37
Environmental Burkholderia cepacia complex isolates in human infections. Emerg Infect Dis (2007) 1.36
Biofilm formation and acyl homoserine lactone production in the Burkholderia cepacia complex. J Bacteriol (2002) 1.32
Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities. J Med Chem (2005) 1.31
Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur J Immunol (2010) 1.26
The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J Leukoc Biol (2006) 1.25
Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun (2005) 1.24
ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin Immunol (2008) 1.23
Exopolysaccharides from Burkholderia cenocepacia inhibit neutrophil chemotaxis and scavenge reactive oxygen species. J Biol Chem (2005) 1.23
Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins. J Immunol (2009) 1.21
Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis. J Infect Dis (2010) 1.21
Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis. J Infect Dis (2007) 1.19
RNA:DNA hybrids are a novel molecular pattern sensed by TLR9. EMBO J (2014) 1.19
Mucoid and nonmucoid Burkholderia cepacia complex bacteria in cystic fibrosis infections. Am J Respir Crit Care Med (2010) 1.18
Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR. J Clin Microbiol (2004) 1.17
Production of exopolysaccharide by Burkholderia cenocepacia results in altered cell-surface interactions and altered bacterial clearance in mice. J Infect Dis (2004) 1.14
Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signaling. J Pediatr (2004) 1.12
Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex. J Clin Microbiol (2008) 1.08
Colonial morphology of Burkholderia cepacia complex genomovar III: implications in exopolysaccharide production, pilus expression, and persistence in the mouse. Infect Immun (2003) 1.08
Animal models of cystic fibrosis. J Cyst Fibros (2004) 1.06
Mycobacterium tuberculosis Cpn60.2 and DnaK are located on the bacterial surface, where Cpn60.2 facilitates efficient bacterial association with macrophages. Infect Immun (2009) 1.05
Plasminogen kringle 5 induces apoptosis of brain microvessel endothelial cells: sensitization by radiation and requirement for GRP78 and LRP1. Cancer Res (2009) 1.05
IRAK-4 mutation (Q293X): rapid detection and characterization of defective post-transcriptional TLR/IL-1R responses in human myeloid and non-myeloid cells. J Immunol (2006) 1.04
Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing. J Clin Microbiol (2007) 1.04
Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection. Clin Immunol (2006) 1.03
Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37. Am J Respir Cell Mol Biol (2005) 1.02
Burkholderia cenocepacia induces neutrophil necrosis in chronic granulomatous disease. J Immunol (2005) 1.02
C5a mediates peripheral blood neutrophil dysfunction in critically ill patients. Am J Respir Crit Care Med (2009) 1.01
Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility. Pediatr Infect Dis J (2005) 1.00
Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain. Am J Respir Cell Mol Biol (2005) 0.98
C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patients. Blood (2011) 0.98
Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence. Microbiology (2011) 0.97
Identification of hopanoid biosynthesis genes involved in polymyxin resistance in Burkholderia multivorans. Antimicrob Agents Chemother (2011) 0.97
In vitro susceptibility of Burkholderia vietnamiensis to aminoglycosides. Antimicrob Agents Chemother (2011) 0.94
Pseudomonas aeruginosa enhances production of a non-alginate exopolysaccharide during long-term colonization of the cystic fibrosis lung. PLoS One (2013) 0.94
Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages. J Leukoc Biol (2009) 0.93
The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium. Am J Respir Cell Mol Biol (2010) 0.93
Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life. Clin Vaccine Immunol (2012) 0.93
Burkholderia phenoliruptrix sp. nov., to accommodate the 2,4,5-trichlorophenoxyacetic acid and halophenol-degrading strain AC1100. Syst Appl Microbiol (2004) 0.92
The role of mucoidy in virulence of bacteria from the Burkholderia cepacia complex: a systematic proteomic and transcriptomic analysis. J Infect Dis (2010) 0.92
Ontogeny of Toll-like receptor mediated cytokine responses of South African infants throughout the first year of life. PLoS One (2012) 0.92
Trappin-2 promotes early clearance of Pseudomonas aeruginosa through CD14-dependent macrophage activation and neutrophil recruitment. Am J Pathol (2009) 0.92
Cationic host defence peptides: potential as antiviral therapeutics. BioDrugs (2013) 0.92
Proteomic identification and characterization of bacterial factors associated with Burkholderia cenocepacia survival in a murine host. Microbiology (2007) 0.91
Mycobacterium tuberculosis employs Cpn60.2 as an adhesin that binds CD43 on the macrophage surface. Cell Microbiol (2010) 0.89
The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus. PLoS One (2013) 0.88
In vivo-transmigrated human neutrophils are resistant to antiapoptotic stimulation. J Leukoc Biol (2011) 0.87
Influence of common non-synonymous Toll-like receptor 4 polymorphisms on bronchopulmonary dysplasia and prematurity in human infants. PLoS One (2012) 0.87
Antiviral potential of cathelicidins. Future Microbiol (2014) 0.85
Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years' experience. Ann Am Thorac Soc (2015) 0.85
The host defense peptide LL-37 selectively permeabilizes apoptotic leukocytes. Antimicrob Agents Chemother (2008) 0.85
Chronic granulomatous disease: from genetic defect to clinical presentation. Adv Exp Med Biol (2005) 0.85
Differential modulation of innate immune cell functions by the Burkholderia cepacia complex: Burkholderia cenocepacia but not Burkholderia multivorans disrupts maturation and induces necrosis in human dendritic cells. Cell Microbiol (2008) 0.84
Evaluation of a diagnostic polymerase chain reaction assay for Neisseria meningitidis in North America and field experience during an outbreak. Arch Pathol Lab Med (2002) 0.84
Recurrent systemic pneumococcal disease and IRAK4 deficiency. Pediatr Infect Dis J (2007) 0.84
Reliability of multilocus sequence typing of the Burkholderia cepacia complex in cystic fibrosis. J Cyst Fibros (2006) 0.84
An integrated model for developing research skills in an undergraduate medical curriculum: appraisal of an approach using student selected components. Perspect Med Educ (2013) 0.84
Pseudomonas aeruginosa: role in the pathogenesis of the CF lung lesion. Semin Respir Crit Care Med (2003) 0.83
Identification of differentially expressed proteins from Burkholderia pseudomallei isolated during primary and relapsing melioidosis. Microbes Infect (2011) 0.82
Persistence of Burkholderia multivorans within the pulmonary macrophage in the murine lung. Infect Immun (2004) 0.82
Differential post-transcriptional activation of human phagocytes by different Pseudomonas aeruginosa isolates. Cell Microbiol (2004) 0.81
Primary immune deficiencies presenting in adults: seven years of experience from Iran. J Clin Immunol (2005) 0.79
Recurrent subacute post-viral onset of ataxia associated with a PRF1 mutation. Eur J Hum Genet (2013) 0.79
Toll-like receptor gene polymorphisms and preeclampsia risk: a case-control study and data synthesis. Hypertens Pregnancy (2010) 0.78
Total protein extraction and 2-D gel electrophoresis methods for Burkholderia species. J Vis Exp (2013) 0.77
Investigation of aminoglycoside resistance inducing conditions and a putative AmrAB-OprM efflux system in Burkholderia vietnamiensis. Ann Clin Microbiol Antimicrob (2014) 0.77
Robust TLR4-induced gene expression patterns are not an accurate indicator of human immunity. J Transl Med (2010) 0.77
Lysyl 4-aminobenzoic acid derivatives as potent small molecule mimetics of plasminogen kringle 5. Bioorg Med Chem Lett (2004) 0.77
Amphipol-trapped ExbB-ExbD membrane protein complex from Escherichia coli: a biochemical and structural case study. J Membr Biol (2014) 0.77
Effect of Burkholderia cepacia infection in the clinical course of patients with cystic fibrosis: a pilot study in a Sydney clinic. Respirology (2002) 0.76
A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants. Pediatr Infect Dis J (2017) 0.75
Correction: Human β-D-3 Exacerbates MDA5 but Suppresses TLR3 Responses to the Viral Molecular Pattern Mimic Polyinosinic:Polycytidylic Acid. PLoS Genet (2016) 0.75
Letting the CAThelicidin out of the bag, as a therapeutic modulator of the adaptive immune system. Leuk Res (2005) 0.75
Reply: The alveolar macrophage and acute respiratory distress syndrome: a silent actor? Am J Respir Crit Care Med (2014) 0.75
Serum susceptibility in clinical isolates of Burkholderia cepacia complex bacteria: development of a growth-based assay for high throughput determination. Front Cell Infect Microbiol (2012) 0.75
Burkholderia cepacia complex and cystic fibrosis: in search of the smoking gun. Am J Respir Crit Care Med (2004) 0.75